Clinical trials
Terminated Multiple Sclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
191 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 10 |
| 2008 | 8 |
| 2009 | 9 |
| 2010 | 12 |
| 2011 | 13 |
| 2012 | 7 |
| 2013 | 11 |
| 2014 | 8 |
| 2015 | 10 |
| 2016 | 11 |
| 2017 | 15 |
| 2018 | 7 |
| 2019 | 13 |
| 2020 | 8 |
| 2021 | 16 |
| 2022 | 9 |
| 2023 | 6 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 191 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 17 |
| Novartis Pharmaceuticals | 8 |
| Charite University, Berlin, Germany | 4 |
| EMD Serono | 4 |
| GlaxoSmithKline | 4 |
| NYU Langone Health | 4 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 3 |
| Amsterdam UMC, location VUmc | 2 |
| Bristol-Myers Squibb | 2 |
| Centre Hospitalier Universitaire de Saint Etienne | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 191 |
| Multiple Sclerosis, Relapsing-Remitting | 25 |
| Fatigue | 10 |
| Multiple Sclerosis, Chronic Progressive | 9 |
| Muscle Spasticity | 9 |
| Autoimmune Diseases | 7 |
| Parkinson Disease | 6 |
| Nervous System Diseases | 5 |
| Optic Neuritis | 5 |
| Alzheimer Disease | 4 |
Trials
Showing 76 to 100 of 191. Each trial links to its page on Pharma Observatory.
91 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.